Citius Oncology 

$0.5540
13
+$0.02+4.63%Friday 20:00
-$0.03-6.14%Friday 22:14After hours

Statistics

Day High
0.563
Day Low
0.5619
52W High
1.83
52W Low
0.491
Volume
406
Avg. Volume
-
Mkt Cap
58.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 17Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.27
-0.18
-0.1
-0.01
Expected EPS
-0.07
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2022
2023
2024
2025
0Revenue
-24.76MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTOR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Show More
CEO
Leonard L. Mazur
Employees
285
Country
Cayman Islands
ISIN
US17331Y1091

Listings

0 Comments

Share your thoughts

FAQs

What is Citius Oncology stock price today?▼
The current price of CTOR is $0.55 USD — it has increased by +4.63% in the past 24 hours. Watch Citius Oncology stock price performance more closely on the chart.
What is Citius Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Citius Oncology stocks are traded under the ticker CTOR.
Is Citius Oncology stock price growing?▼
CTOR stock has fallen by -4.4% compared to the previous week, the month change is a -43.47% fall, over the last year Citius Oncology has showed a -68.34% decrease.
What is Citius Oncology market cap?▼
Today Citius Oncology has the market capitalization of 58.59M
When is the next Citius Oncology earnings date?▼
Citius Oncology is going to release the next earnings report on December 17, 2026.
What were Citius Oncology earnings last quarter?▼
CTOR earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.07 USD resulting in a -14.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Citius Oncology revenue for the last year?▼
Citius Oncology revenue for the last year amounts to 0 USD.
What is Citius Oncology net income for the last year?▼
CTOR net income for the last year is -24.76M USD.
How many employees does Citius Oncology have?▼
As of November 1, 2026, the company has 285 employees.
In which sector is Citius Oncology located?▼
Citius Oncology operates in the Health & Wellness sector.
When did Citius Oncology complete a stock split?▼
Citius Oncology has not had any recent stock splits.
Where is Citius Oncology headquartered?▼
Citius Oncology is headquartered in CRANFORD, Cayman Islands.